Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-22 Sale | 2025-04-24 5:38 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 235,572 | $0.33421 | $78,731 | 6,650,000 (Indirect) | View |
| 2025-04-15 Sale | 2025-04-17 6:10 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 149,054 | $0.33346 | $49,704 | 6,885,572 (Indirect) | View |
| 2025-04-10 Sale | 2025-04-14 7:14 pm | Xtant Medical Holdings Inc. | XTNT | ORBIMED ADVISORS LLC Orbimed ROF II LLC 10% Owner | 73,114,592 | $0.42 | $30,708,129 | 0 (Indirect) | View |
| 2025-04-09 Sale | 2025-04-11 7:24 pm | Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner | 3,571,428 | $1.59 | $5,678,571 | 15,219,994 (Indirect) | View |
| 2025-04-03 Purchase | 2025-04-04 7:33 pm | Edgewise Therapeutics Inc. | EWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner | 496,771 | $20.13 | $10,000,000 | 443,792 (Indirect) | View |
| 2025-03-24 Sale | 2025-03-26 7:00 pm | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 5,738 | $54.11 | $310,483 | 186,541 (Indirect) | View |
| 2025-03-19 Sale | 2025-03-21 8:00 pm | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 52,429 | $54.02 | $2,831,987 | 187,297 (Indirect) | View |
| 2025-03-10 Sale | 2025-03-12 9:34 pm | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 312,384 | $54.31 | $16,965,596 | 194,209 (Indirect) | View |
| 2025-02-14 Purchase | 2025-02-19 5:52 pm | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 190,672 | $10.6 | $2,020,756 | 747,887 (Indirect) | View |
| 2025-02-10 Purchase | 2025-02-10 4:28 pm | Sionna Therapeutics Inc. | SION | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 550,000 | $18 | $9,900,000 | 3,704,959 (Indirect) | View |
| 2025-01-10 Sale | 2025-01-14 5:17 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 223,219 | $0.63715 | $142,223 | 7,034,626 (Indirect) | View |
| 2025-01-06 Sale | 2025-01-08 6:09 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 147,024 | $0.70265 | $103,306 | 7,257,845 (Indirect) | View |
| 2024-12-20 Sale | 2024-12-26 4:34 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 230,321 | $0.6 | $138,193 | 7,404,869 (Indirect) | View |
| 2024-12-09 Sale | 2024-12-11 5:32 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 62,276 | $0.8348 | $51,988 | 7,635,190 (Indirect) | View |
| 2024-12-04 Sale | 2024-12-06 7:07 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 97,103 | $0.79646 | $77,338 | 7,697,466 (Indirect) | View |
| 2024-10-15 Purchase | 2024-10-17 4:17 pm | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 825,000 | $17 | $14,025,000 | 4,554,873 (Indirect) | View |
| 2024-09-19 Sale | 2024-09-23 4:51 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 39,300 | $0.71 | $27,903 | 7,794,569 (Indirect) | View |
| 2024-09-16 Sale | 2024-09-18 6:38 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 200,131 | $0.73315 | $146,727 | 7,833,869 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:13 pm | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 750,000 | $16 | $12,000,000 | 653,787 (Indirect) | View |
| 2024-08-26 Sale | 2024-08-28 4:26 pm | ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director | 83,695 | $13 | $1,088,035 | 8,288,510 (Indirect) | View |
| 2024-08-21 Sale | 2024-08-23 6:38 pm | ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director | 868,682 | $13.24 | $11,497,963 | 8,372,205 (Indirect) | View |
| 2024-08-13 Sale | 2024-08-15 5:01 pm | Keros Therapeutics Inc. | KROS | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director | 250,000 | $44.01 | $11,002,500 | 119,522 (Indirect) | View |
| 2024-08-13 Purchase | 2024-08-15 4:51 pm | scPharmaceuticals Inc. | SCPH | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC 10% Owner | 500,000 | $4 | $2,000,000 | 252,858 (Indirect) | View |
| 2024-07-15 Sale | 2024-07-17 8:48 pm | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC Director 10% Owner | 56,164 | $10 | $561,640 | 755,635 (Indirect) | View |
| 2024-06-28 Sale | 2024-07-02 4:54 pm | TELA Bio Inc. | TELA | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 428,300 | $4.721 | $2,022,000 | 2,407,242 (Indirect) | View |
| 2024-06-17 Purchase | 2024-06-20 5:19 pm | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 83,334 | $36 | $3,000,024 | 235,391 (Indirect) | View |
| 2024-05-16 Sale | 2024-05-20 5:00 pm | Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 1,033,300 | $22.14 | $22,877,262 | 7,663,349 (Indirect) | View |
| 2024-05-01 Sale | 2024-05-03 5:16 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 29,206 | $14.02 | $409,426 | 3,406,335 (Indirect) | View |
| 2024-04-24 Sale | 2024-04-26 5:01 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 1,781 | $14.06 | $25,041 | 3,435,541 (Indirect) | View |
| 2024-04-19 Sale | 2024-04-23 6:38 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 64,653 | $14.12 | $913,057 | 3,437,322 (Indirect) | View |
| 2024-04-16 Sale | 2024-04-18 5:10 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 16,992 | $14.02 | $238,231 | 3,501,975 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-10 Conversion | 2025-02-10 4:28 pm | N/A N/A | Sionna Therapeutics Inc. | SION | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 7,764,670 | $0 | 3,704,959 (Indirect) | View |
Ownership | 2025-02-06 9:18 pm | N/A N/A | Sionna Therapeutics Inc. | SION | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 0 | $0 | 3,154,959 (Indirect) | View |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 694,444 | $3.6 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 1,233,506 | $0 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Option Award | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 1,443,750 | $4 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 539,062 | $3.2 | 2,677,256 (Indirect) | View | |
| 2024-10-15 Conversion | 2024-10-17 4:17 pm | N/A N/A | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 7,219,578 | $0 | 4,554,873 (Indirect) | View |
Ownership | 2024-10-10 8:09 pm | N/A N/A | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 0 | $0 | 4,868,589 (Indirect) | View |
Ownership | 2024-09-23 4:42 pm | N/A N/A | Traws Pharma Inc. | TRAW | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC 10% Owner | 0 | $0 | 1,278,469 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:13 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 39,876,501 | $0 | 653,787 (Indirect) | View |
Ownership | 2024-09-12 7:14 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 0 | $0 | 3,062,215 (Indirect) | View |
| 2024-05-18 Equity Swap | 2024-05-20 7:47 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 2,680,496 | $0 | 0 (Indirect) | View |